---
figid: PMC6558407__fnins-13-00491-g002
figtitle: PI3K-AKT-mTOR signaling and Metformin targets
organisms:
- Homo sapiens
- Macaca mulatta
- Saimiri sciureus
- Mus musculus
- Rattus norvegicus
- Drosophila melanogaster
- Canis lupus familiaris
- Zea mays
- Akkermansia muciniphila
pmcid: PMC6558407
filename: fnins-13-00491-g002.jpg
figlink: /pmc/articles/PMC6558407/figure/F2/
number: F2
caption: PI3K-AKT-mTOR signaling and Metformin targets. The AKT signaling pathway
  can be triggered by insulin-like growth factor 1 (IGF-1) and insulin, which bind
  to transmembrane receptors tirosine kinase (RTK) leading to IRS-1/2 phosphorylation,
  PI3K activation and subsequent phosphatidylinositol-4,5-bisphosphate (PIP2) to phosphatidylinositol-3,4,5-trisphosphate
  (PIP3) conversion. AKT and PDK1 bind to PIP3 at the plasma membrane, and PDK1 phosphorylates
  the activation loop of AKT at T308. RTK signaling also activates mTOR complex 2
  (mTORC2) through an unknown mechanism, and mTORC2 phosphorylates AKT on S473. Active
  AKT is responsible for the inhibition of negative regulators of mTOR, such as tuberous
  sclerosis complex (TSC1/2), which induces the mTOR activator Rheb, thereby releasing
  the mTOR complex to phosphorylate its targets. mTORC1 activity inhibits autophagy.
  The Metformin enters the cell through organic cation transporters (OCTs) and is
  able to inhibit mTORC1 complex, while also activating AMPK thus leading to autophagy
  activation.
papertitle: Insulin and Autophagy in Neurodegeneration.
reftext: Nat√°lia Prudente de Mello, et al. Front Neurosci. 2019;13:491.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9709179
figid_alias: PMC6558407__F2
figtype: Figure
organisms_ner:
- Homo sapiens
- Rattus norvegicus
- Canis lupus familiaris
- Macaca mulatta
- Mus musculus
- Drosophila melanogaster
redirect_from: /figures/PMC6558407__F2
ndex: 0a274d73-dec6-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6558407__fnins-13-00491-g002.html
  '@type': Dataset
  description: PI3K-AKT-mTOR signaling and Metformin targets. The AKT signaling pathway
    can be triggered by insulin-like growth factor 1 (IGF-1) and insulin, which bind
    to transmembrane receptors tirosine kinase (RTK) leading to IRS-1/2 phosphorylation,
    PI3K activation and subsequent phosphatidylinositol-4,5-bisphosphate (PIP2) to
    phosphatidylinositol-3,4,5-trisphosphate (PIP3) conversion. AKT and PDK1 bind
    to PIP3 at the plasma membrane, and PDK1 phosphorylates the activation loop of
    AKT at T308. RTK signaling also activates mTOR complex 2 (mTORC2) through an unknown
    mechanism, and mTORC2 phosphorylates AKT on S473. Active AKT is responsible for
    the inhibition of negative regulators of mTOR, such as tuberous sclerosis complex
    (TSC1/2), which induces the mTOR activator Rheb, thereby releasing the mTOR complex
    to phosphorylate its targets. mTORC1 activity inhibits autophagy. The Metformin
    enters the cell through organic cation transporters (OCTs) and is able to inhibit
    mTORC1 complex, while also activating AMPK thus leading to autophagy activation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IGF1
  - PDK1
  - PDPK1
  - AKT1
  - AKT2
  - AKT3
  - IRS1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - IARS1
  - IRS2
  - IRS4
  - MAPKAP1
  - MTOR
  - RICTOR
  - MLST8
  - TSC2
  - TSC1
  - CCL26
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - RHEB
  - RHEBP1
  - RPTOR
  - Igf1
  - Pdk1
  - Akt1
  - Irs1
  - Pik3cg
  - Tsc2
  - Mtor
  - Tsc1
  - Prkaa2
  - Rheb
  - Pdpk1
  - Pik3r1
  - Akt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - IRSp53
  - IleRS
  - chico
  - gig
  - Tor
  - SNF4Agamma
  - AMPKalpha
  - Crtc
  - Metformin
---
